CBD oil in Brisbane is regulated to deliver medical cannabis products for best possible treatment. Learn more about medicinal cannabis at Cannatrek now! Accessing affordable cannabis clinics in Brisbane. Book an appointment with our trained CA Clinics doctors for cannabis prescriptions. General practitioners (GPs) and specialists can apply to prescribe medicinal cannabis.
CBD Oil Brisbane
CBD oil (cannabidiol) is derived from the cannabis plant, and is used for therapeutic and medicinal purposes. The quality and efficacy of CBD oil in Brisbane is regulated to deliver a consistent medical cannabis product for best possible treatment outcomes, courtesy of Cannatrek.
CBD oil Brisbane explained
CBD is the second most prevalent active ingredient contained in cannabis. It is derived from hemp, a cousin of marijuana, and medicinal marijuana CBD oil is manufactured in strictly controlled laboratories. CBD doesn’t cause a ‘high’, and in humans, ‘CBD exhibits no effects indicative of any abuse or dependence potential,‘ according to a report from the World Health Organisation.
In 2016, the Australian Government legislated the medicinal cannabis industry, allowing licensed businesses to establish biotech growing and production methods that meet stringent guidelines. Fortunately, Cannatrek was already in motion, and a few short years later is now a leading supplier of CBD oil in Brisbane and Australia.
What is CBD Oil?
The CBD derived from cannabis is blended with a carrier oil to create a variety of medicinal and therapeutic products. CBD doesn’t cause the psychoactive reactions associated with Tetrahydrocannabinol (THC) marijuana products, but it does offer a number of health benefits for a wide range of ailments and illnesses. There are several types of CBD oil products, including:
CBD isolate: A pure form of CBD without other cannabis compounds. CBD oil is derived from the leaves, stalk, and flowers of the hemp plant. Hemp seed oil is derived from the seeds and doesn’t contain CBD.
Full-spectrum CBD: These products are made from cannabis plant extracts such as essential oils and scented plant compounds, and may contain up to 3% THC.
Broad-spectrum CBD: These contain several compounds and cannabinoids but do not typically contain THC.
CBD Oil Products available in Australia
CBD products are most commonly available as oils or tinctures (concentrated extracts) produced under controlled conditions. Treatment options also include CBD produced as capsules or infused into lotions, salves, and other skincare products. CBD oil absorbs readily into the skin without the need to be washed or wiped off. Additional ingredients contained in CBD oil include:
Who might benefit from CBD oil?
CBD users and treating professionals target CBD oil health benefits associated with a wide variety of issues. Major breakthroughs include the effectiveness of CBD in treating childhood epilepsy and other ailments that don’t respond to antiseizure medications. CBD oil may be helpful with:
Anxiety: Studies and clinical trials have shown CBD can reduce anxiety.
Chronic pain: Initial studies suggest that CBD can lower arthritis pain and inflammation.
Insomnia: Many patients claim that CBD oil helps them sleep better.
Multiple Sclerosis: Patients reported almost 30% improvement in muscle stiffness.
Addictions: CBD can help lower the craving for tobacco, alcohol, and other drugs.
Palliative care: CBD can be an adjunct to other palliative care measures.
There are many more medical conditions that can be addressed using CBD oil and other medical marijuana products. All CBD products available in Brisbane are registered with the Therapeutic Goods Administration (TGA). CBD oil is legal in QLD with a doctor’s prescription. Cannatrek partners with cannabis doctors who are authorised prescribers of CBD oil and other medicinal cannabis products.
Medical Cannabis Brisbane
The Queensland CA Clinic is located in Belmont, just east of the Brisbane city centre.
Accessing prescribed medical cannabis in Queensland requires patients to meet some qualifying criteria, therefore the clinic does not accept walk-in appointments. In addition, the COVID-19 pandemic has brought about a change in consultation structure. CA Clinics has catered to its Queensland patients by replacing face-to-face consultations with online, telehealth consultations to ensure that they get the same quality of care they need from the safety and convenience of their homes.
To make the process simple for Queensland, we have easy to arrange complimentary Screening Appointments. This involves a brief evaluation of a patient’s condition to assess if there is evidence supporting the use of medical cannabis treatments for their symptoms, and confirms if they’ve tried other conventional treatments prior to seeking medical cannabis.
What conditions can medical cannabis be approved for?
The five main conditions that the Therapeutic Goods Administration (TGA) provides guidance for the use of medical cannabis are:
- Multiple Sclerosis
- Nausea and Vomiting
- Palliative care
Other common conditions where medical cannabis may be prescribed include, but certainly aren’t limited to:
- Irritable Bowel Diseases
- Temporomandibular joint syndrome
- Cancer and non-cancer chronic pain
- Sleep disorders
It is a requirement for TGA approval that there is some preclinical or clinical evidence that medical cannabis or CBD oil will benefit your condition or reduce symptoms.
How much does medical cannabis in Queensland cost?
Screening Appointments are free and can be booked online here or by calling 1300 991 477. After the Screening Appointment determining whether medical cannabis may provide benefit to your condition, the Initial Consultation is priced at $99. Following that, for patients who continue through the TGA application process, additional costs are applicable.
The cost of ongoing medical cannabis prescriptions has been recorded since medical cannabis was made legal in Australia. Data shows medical cannabis patients are paying an average $51 per month for their medical cannabis prescription.
Medical cannabis and CBD oil prescriptions are not yet covered by the Pharmaceuticals Benefits Scheme, so patients will pay the full cost of the medicine. More information on medical cannabis clinic costs can be found here.
How long do medical cannabis approvals take?
The approval time for medical cannabis is usually within one week after the application submission date. At this time, CA Clinics have found the wait time to be around 3-4 days. Times may vary depending on the complexity of the case, though some applications are granted as speedily as 24 hours.
How long does it take for my medicinal cannabis to arrive?
After your medical cannabis application is approved, the medicine is ordered by your prescribing pharmacist. Unlike other medicines, the pharmacies aren’t allowed to hold stock of medical cannabis products.
Usually, once approved it takes around 1-2 weeks for your medical cannabis prescription to arrive. If the medical cannabis product is sourced from an international supplier it may take a little longer to arrive.
What does a medical cannabis telehealth appointment look like?
If you are not yet familiar with telehealth, you’ll find it to be very similar to being in your doctor’s office. Telehealth appointments are conducted over the phone or via video call. The doctor or nurse will ask you questions about your medical condition and case history.
They will then describe the options available that are relevant to you and which symptoms they might benefit, as well as explain the timeline of the application for TGA approval.
As the doctor cannot conduct any physical examinations – like blood pressure, listening to your breathing or palpating areas of concern – they may ask a few more questions of you or your regular medical practitioners to ensure they have a strong understanding of your individual case and can offer the most suitable treatment options.
Telehealth consultations remove some of the barriers to accessing healthcare for those with whom mobility, time constraints, geographic location or health status makes it difficult for them to access medical treatments.
Prescribing medicinal cannabis
Any registered medical practitioner in Queensland can prescribe medicinal cannabis for any patient with any condition, if they believe it is clinically appropriate and have obtained the required Commonwealth approval.
Medicinal cannabis products are classified as either Schedule 3, Schedule 4 or Schedule 8 controlled substances, most products are not listed on the Australian Register of Therapeutic Goods (ARTG). In circumstances where patients need access to therapeutic goods that are not included in the ARTG, a Therapeutic Goods Administration (TGA) approval is required in order for the medicine to be prescribed.
The Commonwealth Department of Health manages and enables access to:
In Queensland, the Medicines and Poisons (Medicines) Regulation 2021 describes the requirements for prescribing and dispensing S4 and S8 medicines.
Queensland doctors can prescribe Schedule 4 – cannabidiol (CBD) and Schedule 8 – tetrahydrocannabinol (THC) or tetrahydrocannabinol: cannabidiol (THC:CBD) products without a Queensland approval.
Guidance and regulations
- Guidance’s for the use of medicinal cannabis in Australia are a suite of national guidance documents that cover a range of medical conditions, symptoms, and products to be used. The individual documents can be viewed on the TGA’s website.
- The Medicines and Poisons (Medicines) Regulation 2021 outlines specific requirements for dealing with regulated substances, including medicinal cannabis, review the Regulation for more information.
- The Medicines and Poisons Act 2019 provides for the development of departmental standards which outline the minimum requirements for safe and effective management of regulated substances, including medicinal cannabis, review the standards for more information.
When making an application to the TGA, you will need to reference clinical evidence that supports using the specific type of medicinal cannabis product proposed (e.g. THC, CBD, or THC and CBD in combination) for your patient’s medical condition or symptoms.
More research is being done on the uses of medicinal cannabis. The scientific evidence base is limited but suggests that medicinal cannabis may be suitable for:
You may apply for other conditions; however, you will need to supply clinical evidence with your application for this to be considered. There is no evidence that medicinal cannabis is an effective treatment for cancer.
Clinicians should not:
- consider medicinal cannabis as an alternative treatment for cancer.
- defer their standard treatment in favour of using medicinal cannabis.
NSW Cannabis Medicines Advisory Service – (for NSW health practitioners only). However, the Service is also available if:
- You are a medical practitioner in a state or territory outside of NSW but are treating a patient residing in NSW, or
- You are a NSW medical practitioner treating a patient in cross-border areas of NSW.
Commonwealth Department of Health
The Commonwealth Department of Health regulates medicinal cannabis products through the Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC).
Generally, medicines imported into, supplied in, and exported from Australia must be entered in the Australian Register of Therapeutic Goods (ARTG), which is administered by the TGA. However, there are mechanisms available for access to medicines that are not registered on the ARTG.
As most medicinal cannabis products are currently unregistered medicines, access to these products is through the Commonwealth Special Access or Authorised Prescriber Schemes or through a Clinical Trial.
Your legal obligations
The prescriber must:
- adhere to all conditions as detailed in any TGA import licence or permit, if they are the importing party
- comply with any conditions imposed on a TGA approval relating to the medicinal cannabis product(s) being used, including obtaining informed consent in writing from the patient (or the person with the legal authority to consent to the treatment on behalf of the patient) in relation to the proposed use of the specified medicine
- comply with the Departmental standard – monitored medicines when prescribing S8 medicinal cannabis products for dispensing or giving a treatment dose
- comply with the requirement to check QScript prior to prescribing or giving a treatment dose of a monitored medicine, including S8 medicinal cannabis
- report any adverse events, adverse reactions, serious adverse reactions and unexpected reactions to the TGA.
Find a product
Doctors can apply to prescribe both plant-based products and synthetic products when used for a therapeutic purpose, including:
- tinctures: plant material infused in oil or alcohol
- vapour: dried plant material or concentrated cannabis extract is heated in a vaporiser
- capsules or sprays: generally, oil-based capsules taken orally
- pharmaceutical products such as nabiximols.
Smoking in general is harmful, smoking of cannabis products is not supported.
Products currently used in Australia:
provide a list of manufacturers and suppliers for imported and locally produced medicinal cannabis products currently in use in Australia.
- Nabiximols (Sativex), is listed as an approved medicines on the Australian Register of Therapeutic Goods.
- Sativex is a Schedule 8 medicine and is a plant-derived product. In Queensland medical practitioners can prescribe Sativex without requiring an approval from the state or the TGA.
How to make an application
Doctors seeking approval to prescribe medicinal cannabis products that are not registered on the ARTG to a Queensland patient will do so via the TGA’s Online System.
Doctors who have already registered can login to the TGA’s Online System
There is no requirement for a Queensland approval to prescribe S8 or S4 medicinal cannabis.